Showing results (151-160 of 194) with videos related to
Sort By:
Pageof 20
The Journal of Infectious Diseases|August 15, 2018
Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIVFelicity C Fitzgerald, Edouard Lhomme, Kathryn Harris, et al.Journal of Tropical Pediatrics|September 17, 2016
Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor ResistanceRagna S Boerma, Cissy Kityo, T Sonia Boender, et al.The Lancet. Infectious Diseases|May 31, 2024
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trialCissy Kityo, Ivan K Mambule, Joseph Musaazi, et al.Nature Medicine|November 4, 2025
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trialCissy Kityo, Ivan K Mambule, Joseph Musaazi, et al.BMC Health Services Research|August 21, 2014
The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and ZimbabweAdrienne K Chan, Deborah Ford, Harriet Namata, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 CountriesN Sarita Shah, Cissy Kityo, Michael D Hughes, et al.Contemporary Clinical Trials|May 31, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan AfricaFredrick Katongole, Tiyara Arumugam, Angus Jennings, et al.BMC Health Services Research|November 18, 2016
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline studyMisheck J Nkhata, Margaret Muzambi, Deborah Ford, et al.Plos One|May 1, 2012
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabweAntonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, et al.Science Translational Medicine|May 8, 2024
The translational gap for gene therapies in low- and middle-income countriesKevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.Pageof 20